Yi Kong

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Topics

Acute Coronary Syndrome

Antiplatelet Therapy

Top Venues

Journal of medicinal chemistry

International journal of molecular sciences

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Panpan Chen, Cai Chen, Yizheng Zheng, Fangjun Chen, Zhaojun Liu, Shenhong Ren, Hangyu Song, Tongdan Liu, Zhipeng Lu, Hong-Bin Sun, Yi Kong, Haoliang Yuan
Discovery of 2,3-Dihydro[1,4]dioxino[2,3- g ]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency. Journal of medicinal chemistry 67 (7) (2024)
Panpan Chen, Cai Chen, Yizheng Zheng, Fangjun Chen, Zhaojun Liu, Shenhong Ren, Hangyu Song, Tongdan Liu, Zhipeng Lu, Hong-Bin Sun, Yi Kong, Haoliang Yuan
Discovery of 2,3-Dihydro[1,4]dioxino[2,3- g ]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency. Journal of medicinal chemistry (2024)
Panpan Chen, Cai Chen, Yizheng Zheng, Fangjun Chen, Zhaojun Liu, Shenhong Ren, Hangyu Song, Tongdan Liu, Zhipeng Lu, Hong-Bin Sun, Yi Kong, Haoliang Yuan
Discovery of 2,3-Dihydro[1,4]dioxino[2,3- g ]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency. Journal of medicinal chemistry 67 (7) (2024)
Ningning Yao, Zhiping Jia, Yongbin Tian, Shuzeng Hou, Xiao Xiao Yang, Jihong Han, Yajun Duan, Chenzhong Liao, Yi Kong, Zhouling Xie
Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors. Journal of medicinal chemistry 65 (5) (2022)
Yi-Zheng Zheng, Xiao-Ru Ji, Yun-Yang Liu, Shuai Jiang, Xiang-Ying Yu, Zhi-Ping Jia, Yue Zhao, Jun-Qiao Zhang, Jia-Li Zhang, Yi Kong
WPK5, a Novel Kunitz-Type Peptide from the Leech Whitmania pigra Inhibiting Factor XIa, and Its Loop-Replaced Mutant to Improve Potency. Biomedicines 9 (12) (2021)
Zhiping Jia, Yunyang Liu, Xiaoru Ji, Yi-Zheng Zheng, Zhengyang Li, Shuai Jiang, Hongjin Li, Yi Kong
DAKS1, a Kunitz Scaffold Peptide from the Venom Gland of Deinagkistrodon acutus Prevents Carotid-Artery and Middle-Cerebral-Artery Thrombosis via Targeting Factor XIa. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Gamariel Rwibasira Rudinga, Ghulam Jilany Khan, Yi Kong
Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. International journal of molecular sciences 19 (2) (2018)
Tong-Dan Liu, Shen-Hong Ren, Xue Ding, Zhou-Ling Xie, Yi Kong
A Short Half-Life αIIbβ₃ Antagonist ANTP266 Reduces Thrombus Formation. International journal of molecular sciences 19 (8) (2018)
Yi Kong, Qing Sun, Qi Zhao, Yaqiong Zhang
Purification and Characterization of a Novel Antiplatelet Peptide from Deinagkistrodon acutus Venom. Toxins 10 (8) (2018)
Xue Ding, Tong-Dan Liu, Zhou-Ling Xie, Qi Zhao, Yuan Cao, Xiao-Dong Liu, Cai-Hui Wang, Rwibasira Rudinga Gamariel, Xin Ming, Zhi-Yu Li, Yi Kong
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin αIIbβ3. BioMed research international 2016 (2016)